Bookmark
Forward
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors].
Terapevticheskiĭ arkhiv 2013Sizes of these terms reflect their relevance to your search.
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Citation
A S Ametov, L L Kamynina. Nonglycemic effects of dipeptidyl peptidase-4 inhibitors]. Terapevticheskiĭ arkhiv. 2013;85(1):98-102
Mesh Tags
Substances
PMID: 23536954
View Full Text
